4833M 15/850
Generic Name: metformin/pioglitazone
Pill imprint 4833M 15/850 has been identified as Actoplus met 850 mg / 15 mg.
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy.
ActoPlus Met 850 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Actoplus met Images
- Generic Name:
- metformin/pioglitazone
- Imprint:
-
4833M
15/850 - Strength:
- 850 mg / 15 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- 64764-0158
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5553 | Physicians Total Care Inc (repackager) |
| 35356-0130 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Actoplus Met resources
- Actoplus Met
- Actoplus Met (Wolters Kluwer)
- Actoplus Met (Cerner Multum)
- Actoplus Met (Micromedex) - Includes Dosage Information
- Actoplus Met (FDA)
Search Again
